AAAAAA
Results:
1-10
|
Results: 10
Authors:
Laczika, K
Mitterbauer, G
Weltermann, A
Knobl, P
Thalhammer-Scherrer, R
Haas, OA
Lechner, K
Jaeger, U
Citation: K. Laczika et al., Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA), LEUK LYMPH, 36(5-6), 2000, pp. 625-629
Authors:
Stoiser, B
Knobl, P
Fonatsch, C
Haas, OA
Mitterbauer, G
Weltermann, A
Geissler, K
Valent, P
Sperr, W
Pabinger, I
Lechner, K
Jaeger, U
Citation: B. Stoiser et al., Prognosis of patients with a second relapse of acute myeloid leukemia, LEUKEMIA, 14(12), 2000, pp. 2059-2063
Authors:
Kyrle, PA
Minar, E
Hirschl, M
Bialonczyk, C
Stain, M
Schneider, B
Weltermann, A
Speiser, W
Lechner, K
Eichinger, S
Citation: Pa. Kyrle et al., High plasma levels of factor VIII and the risk of recurrent venous thromboembolism., N ENG J MED, 343(7), 2000, pp. 457-462
Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo
Authors:
Weltermann, A
Wolzt, M
Petersmann, K
Czerni, C
Graselli, U
Lechner, K
Kyrle, PA
Citation: A. Weltermann et al., Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo, ART THROM V, 19(7), 1999, pp. 1757-1760
Authors:
Fiegl, M
Mitterbauer, G
Weltermann, A
Pirc-Danoewinata, H
Jager, U
Citation: M. Fiegl et al., Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy, LEUK LYMPH, 35(3-4), 1999, pp. 409-413
Authors:
Meidlinger, P
Knobl, P
Jager, U
Gisslinger, H
Pabinger, I
Weltermann, A
Lechner, K
Geissler, K
Citation: P. Meidlinger et al., Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment, ANN HEMATOL, 78(7), 1999, pp. 299-304
Authors:
Agis, H
Weltermann, A
Mitterbauer, G
Thalhammer, R
Edelhauser, M
Seewann, HL
Valent, P
Lechner, K
Fonatsch, C
Geissler, K
Citation: H. Agis et al., Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia, ANN HEMATOL, 78(7), 1999, pp. 329-332
Authors:
Fiegl, M
Weltermann, A
Stindl, R
Fonatsch, C
Lechner, K
Gisslinger, H
Citation: M. Fiegl et al., Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature, ANN HEMATOL, 78(7), 1999, pp. 335-338
Authors:
Eichinger, S
Weltermann, A
Philipp, K
Hafner, E
Kaider, A
Kittl, EM
Brenner, B
Mannhalter, C
Lechner, K
Kyrle, PA
Citation: S. Eichinger et al., Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden, THROMB HAEM, 82(4), 1999, pp. 1232-1236
Authors:
Fureder, W
Weltermann, A
Chott, A
Gisslinger, H
Valent, P
Jager, U
Geissler, K
Lechner, K
Citation: W. Fureder et al., Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine), WIEN KLIN W, 111(24), 1999, pp. 1027-1030
Risultati:
1-10
|